Revolution Medicines, Inc. is 15.6x more valuable than Vericel Corp by market capitalization ($30.74 B vs $1.98 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VCEL | RVMD |
|---|---|---|
| Market cap | $1.98 B | $30.74 B |
| US-listed rank | #2116 | #453 |
| Revenue (latest FY) | $276.26M | $0.00 |
| Net income (latest FY) | $16.52M | -$1.13B |
| Net margin | 6.0% | - |
| P/E (trailing FY) | 119.6 | - |
| SEC filings | 1,674 | 782 |
Revolution Medicines, Inc. is 15.6x more valuable than Vericel Corp by market capitalization ($30.74 B vs $1.98 B).
In their latest fiscal years, Vericel Corp reported $276.26M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Vericel Corp and Revolution Medicines, Inc., or browse the full rankings.